Tvardi Therapeutics, Inc. (TVRD) — Financial Flexibility Index
Tvardi Therapeutics, Inc. (TVRD) has a Financial Flexibility Index of -0.52x as of March 2026. Free cash flow of $-5.86 Million (operating CF $-5.86 Million minus capex $0.00) represents -1% of total liabilities ($11.31 Million). Check how tangible is Tvardi Therapeutics, Inc.'s equity to evaluate the tangible quality of the company's equity base.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Tvardi Therapeutics, Inc. Financial Flexibility Index (2020–2025)
Historical Financial Flexibility Index trend for Tvardi Therapeutics, Inc. across 6 annual periods. For the full cash flow conversion analysis, see cash flow conversion of Tvardi Therapeutics, Inc..
Annual Financial Flexibility Index for Tvardi Therapeutics, Inc. (2020–2025)
Year-by-year free cash flow to debt coverage for Tvardi Therapeutics, Inc.. Explore TVRD operating cash flow to total debt to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -2.11x | $-23.50 Million | $-23.50 Million | $11.13 Million | ▼ -70.8% |
| 2024 | -1.24x | $-59.87 Million | $-60.92 Million | $48.42 Million | ▼ -490.0% |
| 2023 | -0.21x | $-18.66 Million | $-21.04 Million | $89.06 Million | ▼ -6.0% |
| 2022 | -0.20x | $-17.82 Million | $-17.87 Million | $90.15 Million | ▲ +93.6% |
| 2021 | -3.07x | $-60.05 Million | $-60.09 Million | $19.53 Million | ▼ -1225.6% |
| 2020 | -0.23x | $-5.14 Million | $-5.49 Million | $22.16 Million | — |